Actualités

Cameco (NYSE:CCJ) executives said first-quarter 2026 results were in line with the company’s annual plan and reiterated full-year guidance, while offering extensive commentary on the outlook for nuclear power, uranium contracting, and growth opportunities tied to Westinghouse’s AP1000 reactor techno

Nuclear stocks Cameco and BWX Technologies both traded near buy points on Tuesday morning after reporting better-than-expected first-quarter earnings. Cameco is the "sole vertically integrated nuclear company," from uranium mining and refining to providing the reactor core via its 49% stake in Westinghouse Electric, William Blair analyst Jed Dorsheimer wrote in an April 20 coverage initiation. BWX is the U.S. Navy's main nuclear reactor supplier though its recent growth is being fueled by its commercial business.

Cameco (CCJ) delivered earnings and revenue surprises of +18.26% and +24.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ameresco (AMRC) delivered earnings and revenue surprises of -22.22% and +10.27%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

UUUU is headed for a Q1 loss despite surging uranium revenues and volumes, due to higher costs. Rich valuation suggests investors may wait for a better entry.

CCJ nears Q1 results with lower uranium volumes but higher prices, pointing to earnings growth despite softer revenues and a low likelihood of a beat.

Excelerate Energy (EE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Lightbridge (NASDAQ:LTBR) used its first-quarter 2026 business update to highlight progress in intellectual property protection, fuel development and testing partnerships, and expanded internal engineering capabilities, alongside an increase in quarterly losses tied largely to higher research spendi

Centrus Energy heads into Q1 earnings with falling EPS estimates, rising uranium prices and delayed shipments that could shift margins and revenues.